Health Risk Assessment

Simplified 10‑year cardiovascular risk estimation based on Framingham Heart Study methodology. Interactive dashboard, BMI, and lifestyle guidance. Not a substitute for clinical evaluation.

Educational purpose only — This tool uses a simplified risk model for awareness and learning. For clinical risk assessment, please use the official ACC/AHA ASCVD Risk Estimator and consult a qualified healthcare provider.
20–89 years
? Low-risk profile (young, healthy)
? Moderate risk (mid-age, elevated BP)
? High-risk profile (multiple factors)
⭐ Ideal metrics (optimal health)
Privacy guaranteed: All calculations are performed locally in your browser. No data is transmitted or stored.

Understanding Cardiovascular Risk Assessment

Cardiovascular disease (CVD) remains the leading cause of death globally. The Vitalis Health Risk Assessment uses a simplified version of the Framingham Heart Study general CVD risk model (D’Agostino et al., Circulation 2008) to estimate the 10‑year risk of a first atherosclerotic event. This tool incorporates the core risk factors identified by the American College of Cardiology / American Heart Association (ACC/AHA) and the World Health Organization: age, sex, blood pressure, cholesterol, smoking, diabetes, and hypertension treatment.

How the simplified model works: Each risk factor is assigned points based on sex‑specific tables. The total points are mapped to a 10‑year risk percentage. The algorithm is calibrated for adults aged 20–79 and provides a directional estimate for educational insight.

Why Risk Awareness Matters

  • Early prevention – identifying elevated risk enables lifestyle changes (diet, exercise, smoking cessation) and timely medical consultation.
  • Shared decision‑making – risk scores help patients and clinicians discuss preventive therapies like statins and blood pressure control.
  • Track progress – repeated assessments can show improvements after interventions.

Scientific Foundation & Limitations

The Framingham Risk Score has been validated in multiple populations and remains a cornerstone of primary prevention. However, this educational tool uses a simplified point‑based method rather than the full Cox regression equations. As a result, the exact risk percentages may differ from the official ACC/AHA Pooled Cohort Equations, which also incorporate race and additional factors. Important risk modifiers not captured here include: family history of premature CVD, chronic kidney disease, chronic inflammatory conditions, premature menopause, metabolic syndrome, and elevated lipoprotein(a). Users with any of these should consider themselves at potentially higher risk.

For a comprehensive assessment, the ACC/AHA ASCVD Risk Estimator is the recommended clinical tool.

Step-by-Step Interpretation Guide

  1. Enter your health metrics accurately (age, BP, lipids, etc.).
  2. The tool calculates risk points and displays an estimated 10‑year risk percentage.
  3. BMI, BP status, and cholesterol ratio provide additional metabolic context.
  4. Review the personalized recommendations. If your risk is moderate or high, consider discussing preventive strategies with a healthcare provider.

Reference Risk Scenarios

Profile Key Metrics Estimated 10‑Year Risk Clinical Implication
Low-risk 35‑year male Non-smoker, BP 110/70, TC 160, HDL 55 <1% Reassurance; maintain healthy lifestyle
Borderline 58‑year female SBP 138, non-smoker, TC 210, HDL 42 5‑7% Lifestyle optimization; consider BP monitoring
Moderate-risk 62‑year male SBP 148 (on meds), TC 240, HDL 35, smoker 12‑16% Statin therapy likely indicated; intensive lifestyle changes
High-risk 65‑year with diabetes SBP 152 (treated), TC 260, HDL 32, smoker >20% High-intensity statin, strict BP control, glucose management
Case Study: Using Risk Awareness for Change

A 54‑year‑old male with BMI 30, SBP 144 mmHg, total cholesterol 225 mg/dL, HDL 38 mg/dL, and a 10‑year smoking history received an estimated risk of 14%. After 8 months of structured lifestyle intervention (Mediterranean diet, smoking cessation, and regular exercise), his updated risk estimate dropped to 8%. This illustrates the power of modifiable risk factors. While this tool is educational, it can motivate positive health behavior.

Frequently Asked Questions

No. This is an educational tool designed for awareness. Always consult a healthcare provider for clinical decisions, diagnostic tests, and treatment plans.

A simplified Framingham general CVD risk model with sex‑specific point tables (based on D’Agostino et al., 2008). It provides an educational estimate; for clinical use, refer to the ACC/AHA ASCVD Risk Estimator.

Family history of premature heart disease, chronic kidney disease, metabolic syndrome, chronic inflammation, and ethnicity/race are not incorporated. These can modify risk independently.

The Framingham model is validated for ages 20–79. For younger individuals, absolute risk is very low, but healthy habits established early are crucial for long‑term prevention.
References: D’Agostino RB et al., Circulation 2008; AHA/ACC Guideline on Primary Prevention of CVD (2019); WHO CVD Risk Charts. Last updated: March 2026. This tool is developed by GetZenQuery’s data science team and reviewed for accuracy against published guidelines.